You may know that Toni Braxton herself was diagnosed with lupus a while ago. This is a severe autoimmune disease, and whoever suffers from the symptoms knows.
Toni started supporting a new campaign: the Lupus LA Awareness Campaign, and people are praising her initiative.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.